Literature DB >> 15885886

Transfection of mouse macrophage metalloelastase gene into murine CT-26 colon cancer cells suppresses orthotopic tumor growth, angiogenesis and vascular endothelial growth factor expression.

Hai Shi1, Jian Ming Xu, Nai Zhong Hu, Xue Long Wang, Qiao Mei, Yu Lin Song.   

Abstract

A cDNA fragment coding for domains I and II of mouse macrophage metalloelastase (MME) was transfected into murine CT-26 colon cancer cells that are MME deficient. An orthotopic implantation model was established by using MME-transfected cells. In MME-transfected primary tumors, it demonstrated that tumor growth and microvessel formation were significantly inhibited compared with the controls. The expression of vascular endothelial growth factor (VEGF) mRNA and protein was significantly lower in MME-transfected group compared with those in the controls. Our data show that both MME and VEGF gene expression is highly associated with the vascularity of tumors, which may depend on a balance between MME and VEGF expression.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 15885886     DOI: 10.1016/j.canlet.2005.03.010

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  3 in total

Review 1.  Matrix metalloproteinases: protective roles in cancer.

Authors:  Julie Decock; Sally Thirkettle; Laura Wagstaff; Dylan R Edwards
Journal:  J Cell Mol Med       Date:  2011-06       Impact factor: 5.310

2.  The role of matrix metalloproteinases in colorectal cancer.

Authors:  Anan H Said; Jean-Pierre Raufman; Guofeng Xie
Journal:  Cancers (Basel)       Date:  2014-02-10       Impact factor: 6.639

Review 3.  Insights into the Role of Matrix Metalloproteinases in Precancerous Conditions and in Colorectal Cancer.

Authors:  Zahra Pezeshkian; Stefania Nobili; Noshad Peyravian; Bahador Shojaee; Haniye Nazari; Hiva Soleimani; Hamid Asadzadeh-Aghdaei; Maziar Ashrafian Bonab; Ehsan Nazemalhosseini-Mojarad; Enrico Mini
Journal:  Cancers (Basel)       Date:  2021-12-10       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.